What is CVE-2026-32917?

CVE-2026-32917 is a critical-severity vulnerability in Openclaw, classified under OS Command Injection. CVSS score: 9.8/10. Published 2026-03-31.

How severe is CVE-2026-32917?

Critical severity. CVSS v3 base score is 9.8 out of 10.

RCE in Openclaw

CVE-2026-32917

OpenClaw before 2026.3.13 contains a remote command injection vulnerability in the iMessage attachment staging flow that allows attackers to execute arbitrary commands on configured remote hosts. The vulnerability exists because unsanitize…

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.006 (69.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Openclaw — versions 0, 2026.3.13

Weakness classification (CWE)

CWE-78 — OS Command Injection

References

GitHub Security Advisory (GHSA-g2f6-pwvx-r275) (third-party-advisory)
Patch Commit (patch)
VulnCheck Advisory: OpenClaw < 2026.3.13 - Remote Command Injection via Unsanitized iMessage Attachment Paths in SCP (third-party-advisory)

Frequently asked questions

What is CVE-2026-32917?: CVE-2026-32917 is a critical-severity vulnerability in Openclaw, classified under OS Command Injection. CVSS score: 9.8/10. Published 2026-03-31.
How severe is CVE-2026-32917?: Critical severity. CVSS v3 base score is 9.8 out of 10.